• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 94 of 100
Inside Teva Pharmaceuticals Headquarters
Israeli drug firm Teva buys Allergan’s generics business for $40 billion
By Geoffrey SmithJuly 27, 2015
157934085
Finance
Teva in talks to buy Allergan’s generic drug business
By ReutersJuly 26, 2015
World’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
Features
World’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
By Laura LorenzettiJuly 24, 2015
Just like with regular sports, eSports athletes will be tested for drugs
Tech
Just like with regular sports, eSports athletes will be tested for drugs
By Chris MorrisJuly 24, 2015
Fight against Daesh in Turkey's Syrian borderline
Features
ISIS and drug sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithJuly 24, 2015
Cancer research laboratory
Leadership
Doctors say cancer drug costs are out of control
By Claire GrodenJuly 23, 2015
Apple aftershock and a new frontier for Alzheimer’s treatments–5 things to know today
Features
Apple aftershock and a new frontier for Alzheimer’s treatments–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 22, 2015
peanuts
Tech
How one startup plans to end the EpiPen monopoly
By Corinne IozzioJuly 21, 2015
Apple Worldwide Developers Conference Opens In San Francisco
Features
Apple, Greek banks, and earnings — 5 things to know this week
By Tom Huddleston Jr.July 19, 2015
Pharma M&A boom rolls on: now Celgene’s buying Receptos
Tech
Pharma M&A boom rolls on: now Celgene’s buying Receptos
By Geoffrey SmithJuly 15, 2015
Vida Health and AstraZeneca launch new app for post-heart attack recovery
Tech
Vida Health and AstraZeneca launch new app for post-heart attack recovery
By Laura LorenzettiJuly 14, 2015
Meet BioBot, the ‘MakerBot of biology’
Tech
Meet BioBot, the ‘MakerBot of biology’
By Andrew ZaleskiJuly 13, 2015
Novartis senses a blockbuster after FDA approves its new heart drug
Tech
Novartis senses a blockbuster after FDA approves its new heart drug
By Geoffrey SmithJuly 9, 2015
CVS Health leaving U.S. Chamber of Commerce over smoking spat
Retail
CVS Health leaving U.S. Chamber of Commerce over smoking spat
By Phil WahbaJuly 8, 2015
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By Tom Huddleston Jr.July 7, 2015
1...
  • 92
  • 93
  • 94
  • 95
  • 96
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’placeholder alt text
By Preston ForeSeptember 20, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.